Partners Plx 3

Our Partners

HOW WE COLLABORATE

Working together with academics and pharma, we drive innovation and accelerate programmes through to clinical readiness.

We understand that every drug discovery idea is unique. That’s why we work with you to address your specific challenges and goals, ensuring you receive the support you need at every stage of your journey.

Partners New

What we bring to our partnerships:

  • Spirit A collaborative mindset
  • Progression At Pace Progression at pace
  • The Final Product Focus on the final product
  • Patient Centric Approach A patient-centric approach

Our partners

Who we work with to unlock the treatments of tomorrow

Academics

Partnering to launch your ideas

Placing your groundbreaking science at the heart of everything, we bring expertise and resources to help turn your vision into reality. Our deep industry knowhow supports every stage of pre-clinical development, ensuring your discoveries achieve their full potential.

A collaborative approach

Collaboration at Slingshot is built around open communication, shared responsibility and above all trust; a one-team approach with everyone working towards a common goal, together.

Guidance, not guardianship

Focusing on empowering our partners to make informed decisions; we provide the tools, support and direction necessary for growth.

Let’s talk about your idea

Pharma

Partnering for science innovation

We secure your return on investment by developing research ideas into lifechanging therapies – combing high impact potential science from leading academics, our pre-clinical development capabilities and the infrastructure, knowledge and expertise of established R&D organisations.

Bringing innovation to the clinic

Leveraging industry-leading capabilities with the rigour and diligence needed to progress assets through to clinic readiness and licensing; creating an opportunity for a variety of innovative medicines to reach patients.

Productive partnerships

Engaging in transactions with more established pharmaceutical companies to secure the future of valuable assets; our approach is diverse and flexible.

Let’s talk about your pipeline needs